BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10335599)

  • 21. Virus load and antigenic diversity.
    Bittner B; Bonhoeffer S; Nowak MA
    Bull Math Biol; 1997 Sep; 59(5):881-96. PubMed ID: 9281903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dynamical model of human immune response to influenza A virus infection.
    Hancioglu B; Swigon D; Clermont G
    J Theor Biol; 2007 May; 246(1):70-86. PubMed ID: 17266989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective deletion mutant amplification.
    McLeod B; Burroughs N
    J Theor Biol; 2000 Oct; 206(4):449-64. PubMed ID: 11013108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducibility and usability of chronic virus infection model using agent-based simulation; comparing with a mathematical model.
    Itakura J; Kurosaki M; Itakura Y; Maekawa S; Asahina Y; Izumi N; Enomoto N
    Biosystems; 2010 Jan; 99(1):70-8. PubMed ID: 19751799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viruses as antitumor weapons: defining conditions for tumor remission.
    Wodarz D
    Cancer Res; 2001 Apr; 61(8):3501-7. PubMed ID: 11309314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling viral and immune system dynamics.
    Perelson AS
    Nat Rev Immunol; 2002 Jan; 2(1):28-36. PubMed ID: 11905835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunological defense to viral infections: focus on virus-specific T cells].
    de Bree GJ; van Leeuwen EM; ten Berge RJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2440-4. PubMed ID: 18064863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining CTL-induced pathology: implications for HIV.
    Wodarz D; Krakauer DC
    Virology; 2000 Aug; 274(1):94-104. PubMed ID: 10936092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery.
    Wein LM; Wu JT; Kirn DH
    Cancer Res; 2003 Mar; 63(6):1317-24. PubMed ID: 12649193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The persistence of CTL memory.
    Wodarz D
    Neth J Med; 2002 Aug; 60(7 Suppl):4-13; discussion 14-6. PubMed ID: 12430586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structured model of influenza virus replication in MDCK cells.
    Sidorenko Y; Reichl U
    Biotechnol Bioeng; 2004 Oct; 88(1):1-14. PubMed ID: 15384040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of HIV-1 drug resistance during antiretroviral treatment.
    Rong L; Feng Z; Perelson AS
    Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replicative homeostasis: a mechanism of viral persistence.
    Sallie R
    Med Hypotheses; 2004; 63(3):515-23. PubMed ID: 15288380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral gene therapy.
    von Laer D; Baum C; Protzer U
    Handb Exp Pharmacol; 2009; (189):265-97. PubMed ID: 19048204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling plasma virus concentration during primary HIV infection.
    Stafford MA; Corey L; Cao Y; Daar ES; Ho DD; Perelson AS
    J Theor Biol; 2000 Apr; 203(3):285-301. PubMed ID: 10716909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pest control through viral disease: mathematical modeling and analysis.
    Bhattacharyya S; Bhattacharya DK
    J Theor Biol; 2006 Jan; 238(1):177-97. PubMed ID: 16005904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ regulatory T cells in persistent human viral infections.
    Billerbeck E; Thimme R
    Hum Immunol; 2008 Nov; 69(11):771-5. PubMed ID: 18789990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional signatures of protective antiviral T-cell immunity in human virus infections.
    Harari A; Dutoit V; Cellerai C; Bart PA; Du Pasquier RA; Pantaleo G
    Immunol Rev; 2006 Jun; 211():236-54. PubMed ID: 16824132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of HIV-1 kinetic models using quantitative discrimination analysis.
    Knorr AL; Srivastava R
    Bioinformatics; 2005 Apr; 21(8):1668-77. PubMed ID: 15613395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.